No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
BLFS250117C20000
- 6.99
- -0.01-0.14%
15min DelayTrading Jan 10 10:13 ET
6.99High6.99Low
6.99Open7.00Pre Close1 Volume2 Open Interest20.00Strike Price699.00Turnover183.20%IV2.82%PremiumJan 17, 2025Expiry Date6.25Intrinsic Value100Multiplier7DDays to Expiry0.74Extrinsic Value100Contract SizeAmericanOptions Type0.8851Delta0.0288Gamma3.89Leverage Ratio-0.0928Theta0.0032Rho3.44Eff Leverage0.0071Vega
Intraday
- 5D
- Daily
News
Craig-Hallum Maintains BioLife Solutions(BLFS.US) With Buy Rating
Is BioLife Solutions, Inc. (NASDAQ:BLFS) Potentially Undervalued?
Northland Securities Maintains BioLife Solutions(BLFS.US) With Buy Rating, Raises Target Price to $31
Maxim Group Initiates BioLife Solutions(BLFS.US) With Buy Rating, Announces Target Price $34
Northland Capital Markets Maintains Outperform on BioLife Solns, Raises Price Target to $31
BioLife Solns Analyst Ratings